MKI67 and breast cancer: Further, immunohistochemistry showed decreased percentage of Ki-67-positive cells (24.46%±2.45) within breast cancer tissue of DE-EDCP treated mice compared to vehicle and cisplatin treated animals (36.05%±2.94 and 36.66%±3.47, respectively) (Figure 6B and 6C).